Additional information
Colourless semisolid
77517-29-4
ACI-121505
(1S,3S,4aR,7S,8S,8aS)-8-2-(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-ylethyl-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl(2S)-2- methylbutanoate
(1S,3S,4aR,7S,8S,8aS)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl (2S)-2-methylbutanoate
C24H38O5
406.56
Ambient
2-8°C
Dihydro Lovastatin;(2S)-2-Methylbutanoic Acid (1S,3S,4aR,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-Octahydro- 3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester; (+)-Dihydromevinolin;
Anticholesteremic agent





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)